Dipna Pharmachem Limited

DPL

INE0MC401013

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-06-10 am EDT			5-day change	1st Jan Change
8.13 ^INR	-1.33%		-3.44%	-23.66%

Apr. 25	Dipna Pharmachem Limited announced a financing transaction	CI
Apr. 02	Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7%	MT

Dipna Pharmachem Limited Appoints Jitendra Parmar as Independent Director of the Company, with Effect from May 1, 2023

April 29, 2023 at 08:24 am EDT

Dipna Pharmachem Limited announced that at the board meeting held on April 29, 2023, the company approved the appointment of Mr. Jitendra Parmar as the Independent Director of the Company, with effect from May 1, 2023. Experience & expertise is Practicing Company Secretary with 6 years experience. Qualification is 1. Company Secretary 2. Master of Commerce from Saurashtra University.

3. Graduation from Saurashtra University.

Latest news about Dipna Pharmachem Limited

Dipna Pharmachem Limited announced a financing transaction	Apr. 24	CI
Dipna Pharmachem Bags INR127.5 Million Order for Melamine Powder; Shares Jump 7%	Apr. 02	MT
Dipna Pharmachem Limited Announces Resignation of Chinu Kalal as Non-Executive Independent Director	Jan. 20	CI
Dipna Pharmachem Limited Announces Appointment of Madhuri Gurwani as Company Secretary and Compliance Officer	Dec. 15	CI
Dipna Pharmachem Limited Reports Earnings Results for the Half Year Ended September 30, 2023	23-10-18	CI
200 Equity Shares of Dipna Pharmachem Limited are subject to a Lock-Up Agreement Ending on 20-SEP-2023.	23-09-19	CI
5,572,800 Equity Shares of Dipna Pharmachem Limited are subject to a Lock-Up Agreement Ending on 19-SEP-2023.	23-09-18	CI
Dipna Pharmachem Limited Announces Resignation of Ms. Khushboo Jethaliya as Company Secretary / Compliance Officer	23-08-21	CI
Dipna Pharmachem Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-10	CI
Dipna Pharmachem Limited Appoints Jitendra Parmar as Independent Director of the Company, with Effect from May 1, 2023	23-04-29	CI
Dipna Pharmachem Limited Announces Resignation of Chinu Kalal from the Post of the Independent Director	23-01-31	CI
Dipna Pharmachem Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
Dipna Pharmachem Limited has filed an IPO in the amount of INR 152.076 million.	22-07-14	CI

Chart Dipna Pharmachem Limited

Duration

Period

More charts

Company Profile

Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company's products include albendazole, ambroxol HCL, amisulpride IP/BP, amoxicillin aripiprazole IP, artemether, azithromycin, cefixime, carbamezapin, calcium gluconate IP, cefadroxyl monohydrate IP/BP/EP cephalexin, clindamycin phosphate IP/BP/USP, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine gluconate 20% solution, chlorhexidine hydrochloride, chlorhexidine acetate, dapoxetine HCL, dextromethorphan hydrobromic (DMR), diclofenac potassium, diclofenac sodium, dried alluminiumhydroxide IP, ferric ammounium citrate IP, ferrous ascorbate, folic acid IP, guaiphenesin IP, griseofulvin IP /BP, hydrocortisone acetate, ibuprofen IP, levofloxacin, lumefantrine, lidocaine base, lidocaine hydrochloride, lornoxicam, metronidazole plain/benzoate and mefenamic acid IP.

Sector

Specialty Chemicals

More about the company

Income Statement Evolution

More financial data

Sector Specialty Chemicals Wholesale

	1st Jan change	Capi.
DIPNA PHARMACHEM LIMITED	-23.66%	2.37M
IMCD N.V.	-11.11%	8.66B
REDOX LIMITED	+29.79%	1.05B
TOPCO TECHNOLOGIES CORP.	+10.21%	177M
GHW INTERNATIONAL	+63.41%	172M
HP ADHESIVES LIMITED	-3.79%	106M
SHANKAR LAL RAMPAL DYE-CHEM LIMITED	+1.82%	84.23M